Dental enamel formation is a tightly regulated developmental process that is particularly vulnerable to disruption during early life, leading to permanent enamel defects such as molar incisor hypomineralization. While epidemiological studies have linked certain environmental factors and medical treatments to developmental defects of enamel, direct causal evidence in humans remains limited due to the lack of suitable in vitro models. Here, we use human epithelial tooth organoids to examine the effects of clinically relevant environmental and pharmacological exposures, including amoxicillin, bisphenol A, vinblastine, and vincristine on ameloblast differentiation and maturation. Organoids were exposed during defined stages of differentiation, followed by gene expression analysis, viability assays, transcriptomic profiling, and ultrastructural characterization. Exposure to amoxicillin, vinblastine, and vincristine impaired ameloblast maturation, as evidenced by reduced expression of maturation-stage enamel matrix proteins, including AMTN and ODAM , without markedly affecting overall cell viability or organoid morphology. Transcriptomic analysis of amoxicillin-treated organoids revealed selective downregulation of metabolic and secretory pathways, including oxidative phosphorylation, glycolysis, and unfolded protein response. Furthermore, epithelial tooth organoids recapitulated known mechanisms of action of chemotherapeutic agents, such as α-tubulin depolymerization. These findings indicate that the external exposures investigated can interfere with ameloblast maturation programs in a human-derived in vitro system. Our study establishes human epithelial tooth organoids as a robust platform to model exposure-induced disruptions in amelogenesis and provides direct experimental evidence that commonly encountered environmental and pharmacological agents can impair enamel development. This model offers new opportunities to investigate the mechanisms underlying developmental defects of enamel in a human-relevant context.
No takes yet. Share an insight, caveat, or question.
Hasevoets et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: